About Limbix
Limbix is a company based in Palo Alto (United States) founded in 2016 was acquired by BigHealth in July 2023. Limbix has raised $27 million across 6 funding rounds from investors including NIH, Korea Investment Holdings and HHS. The company has 55 employees as of December 31, 2022. Limbix offers products and services including Sleepio, Daylight, and Spark Direct. Limbix operates in a competitive market with competitors including Mindoula, Woebot Health, PursueCare, Click Therapeutics and Healios, among others.
- Headquarter Palo Alto, United States
- Employees 55 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Limbix
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Limbix
Limbix offers a comprehensive portfolio of products and services, including Sleepio, Daylight, and Spark Direct.
Program to improve sleep quality using CBT techniques.
Program for managing worry and anxiety effectively.
Program to enhance mood and well-being through behavioral methods.
People of Limbix
Unlock access to complete
Unlock access to complete
Funding Insights of Limbix
Limbix has successfully raised a total of $27M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Limbix
Limbix has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Korea Investment Holdings and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech startups are invested in by GSR Ventures.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital firm focused on software, fintech, marketplaces, and consumer internet
|
Locked | Locked | Locked |
Investor details for Limbix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Limbix
Investment portfolio details for Limbix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Limbix
Detailed financials for Limbix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Limbix Comparisons
Peer comparison for Limbix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Limbix
Limbix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mindoula, Woebot Health, PursueCare, Click Therapeutics and Healios, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Virtual care management for behavioral health is provided by Mindoula.
|
|
| Locked | Locked | Locked |
AI-powered chat-based mental wellness tools are developed.
|
|
| Locked | Locked | Locked |
Addiction treatment is delivered via mobile app teleconsultations.
|
|
| Locked | Locked | Locked |
Mobile apps for brain disorder treatments are provided.
|
|
| Locked | Locked | Locked |
Digital therapeutics for mental and physical illnesses are provided online.
|
Detailed competitors of Limbix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Limbix
Complete news archive for Limbix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Limbix
Limbix was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Limbix is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Limbix is a funded company, having raised a total of $27M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Limbix is 55.
Provider of VR-based stress management solutions. It provides a platform that enables therapists to administer virtual reality exposure therapy solutions to help patients overcome anxiety, phobia, obsessive-compulsive disorder, and substance abuse. Its platform allows therapists to manage their patient exposure levels within VR scenes providing personalized treatment. Therapists can log in to the platform to add patients, create assignments, and monitor progress. Patients can then use a mobile app to complete action plans, enter thought records and assessments, listen to guided meditations and provide therapist feedback.
Limbix's top competitors include PursueCare, Click Therapeutics and Woebot Health.
Limbix offers Sleepio, Daylight, and Spark Direct.
Limbix has 18 investors. Key investors include NIH, Korea Investment Holdings, HHS, BigHealth, and NextGen Venture Partners.